Cargando…
Properties of an Oral Preparation Containing a Chitosan Salt
The 2-(4-chlorophenoxy)-2-methylpropionic acid (CMP) salt of chitosan (CS), CS-CMP, and that of a CS derivative (CP), were prepared and their ability to adsorb bile acids investigated. CS-CMP and CP-CMP rapidly adsorbed taurocholate (TCA) and glycocholate (GCA) when these bile acids were present tog...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253835/ https://www.ncbi.nlm.nih.gov/pubmed/19223823 http://dx.doi.org/10.3390/molecules14020755 |
_version_ | 1783373585592614912 |
---|---|
author | Murata, Yoshifumi Kodama, Youko Hirai, Daijirou Kofuji, Kyouko Kawashima, Susumu |
author_facet | Murata, Yoshifumi Kodama, Youko Hirai, Daijirou Kofuji, Kyouko Kawashima, Susumu |
author_sort | Murata, Yoshifumi |
collection | PubMed |
description | The 2-(4-chlorophenoxy)-2-methylpropionic acid (CMP) salt of chitosan (CS), CS-CMP, and that of a CS derivative (CP), were prepared and their ability to adsorb bile acids investigated. CS-CMP and CP-CMP rapidly adsorbed taurocholate (TCA) and glycocholate (GCA) when these bile acids were present together in the medium, with simultaneous release of CMP. A secondary bile acid, taurodeoxycholate, was preferentially adsorbed over TCA and GCA. Alginate gel beads containing CS-CMP did not differ from CS-CMP alone in their manner of bile acids take up. Furthermore, oral administration of CS-CMP to rats resulted in decreased serum cholesterol and triacylglycerol levels for two weeks. Therefore, CS-CMP, as well as a vehicle containing CS-CMP, might be a useful agent with which to treat hyperlipidemia. |
format | Online Article Text |
id | pubmed-6253835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Molecular Diversity Preservation International |
record_format | MEDLINE/PubMed |
spelling | pubmed-62538352018-11-30 Properties of an Oral Preparation Containing a Chitosan Salt Murata, Yoshifumi Kodama, Youko Hirai, Daijirou Kofuji, Kyouko Kawashima, Susumu Molecules Communication The 2-(4-chlorophenoxy)-2-methylpropionic acid (CMP) salt of chitosan (CS), CS-CMP, and that of a CS derivative (CP), were prepared and their ability to adsorb bile acids investigated. CS-CMP and CP-CMP rapidly adsorbed taurocholate (TCA) and glycocholate (GCA) when these bile acids were present together in the medium, with simultaneous release of CMP. A secondary bile acid, taurodeoxycholate, was preferentially adsorbed over TCA and GCA. Alginate gel beads containing CS-CMP did not differ from CS-CMP alone in their manner of bile acids take up. Furthermore, oral administration of CS-CMP to rats resulted in decreased serum cholesterol and triacylglycerol levels for two weeks. Therefore, CS-CMP, as well as a vehicle containing CS-CMP, might be a useful agent with which to treat hyperlipidemia. Molecular Diversity Preservation International 2009-02-13 /pmc/articles/PMC6253835/ /pubmed/19223823 http://dx.doi.org/10.3390/molecules14020755 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Communication Murata, Yoshifumi Kodama, Youko Hirai, Daijirou Kofuji, Kyouko Kawashima, Susumu Properties of an Oral Preparation Containing a Chitosan Salt |
title | Properties of an Oral Preparation Containing a Chitosan Salt |
title_full | Properties of an Oral Preparation Containing a Chitosan Salt |
title_fullStr | Properties of an Oral Preparation Containing a Chitosan Salt |
title_full_unstemmed | Properties of an Oral Preparation Containing a Chitosan Salt |
title_short | Properties of an Oral Preparation Containing a Chitosan Salt |
title_sort | properties of an oral preparation containing a chitosan salt |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253835/ https://www.ncbi.nlm.nih.gov/pubmed/19223823 http://dx.doi.org/10.3390/molecules14020755 |
work_keys_str_mv | AT muratayoshifumi propertiesofanoralpreparationcontainingachitosansalt AT kodamayouko propertiesofanoralpreparationcontainingachitosansalt AT hiraidaijirou propertiesofanoralpreparationcontainingachitosansalt AT kofujikyouko propertiesofanoralpreparationcontainingachitosansalt AT kawashimasusumu propertiesofanoralpreparationcontainingachitosansalt |